Edward Adomako: Recognizing Thrombotic Thrombocytopenic Purpura as A Life-Threatening Emergency
Edward Adomako, Biochemist and Molecular Biologist, shared on LinkedIn:
”Thrombotic Thrombocytopenic Purpura (TTP): A Rare but Life-Threatening Medical Emergency
In clinical laboratory medicine, some conditions demand rapid recognition and immediate intervention.
One of these is Thrombotic Thrombocytopenic Purpura (TTP), a rare disorder that can become fatal if not treated promptly.
TTP occurs when there is a severe deficiency of the enzyme ADAMTS13, which normally regulates von Willebrand factor in the blood.
When this enzyme is lacking, abnormal platelet clumping can occur in small blood vessels, leading to microvascular thrombosis.
Key laboratory and clinical features include:
- Severe thrombocytopenia (low platelet count)
- Microangiopathic hemolytic anemia with schistocytes on peripheral smear
- Elevated LDH and bilirubin
- Neurological symptoms such as confusion or seizures
- Possible renal impairment
Historically, clinicians described a ‘pentad’ of symptoms, but in many cases, the combination of thrombocytopenia and hemolytic anemia is enough to raise strong suspicion.
Why early diagnosis matters
Without treatment, mortality from TTP can be extremely high.c
Fortunately, modern therapies such as therapeutic plasma exchange, corticosteroids, and targeted therapies like caplacizumab have dramatically improved survival rates.
The role of the laboratory
Laboratory professionals play a critical role in identifying:
- Schistocytes on peripheral blood smear
- Evidence of hemolysis
- ADAMTS13 activity testing when available
Early laboratory detection can be the difference between rapid life-saving treatment and delayed care.
For healthcare professionals:
Maintaining a high index of suspicion when encountering unexplained thrombocytopenia and hemolytic anemia is crucial.
As laboratory and healthcare professionals, our vigilance helps ensure that rare but critical conditions like TTP are recognized and treated in time.”

Stay updated with Hemostasis Today.
-
Aug 14, 2026, 13:43Edward Lee Carter: Optimizing Anticoagulation in Cirrhosis Beyond the Lab Numbers
-
Aug 14, 2026, 13:39Amr Saad: What Tips You Toward Cerebral Venous Thrombosis Over IIH?
-
Aug 14, 2026, 13:28Eduardo Medronha: DIPS as a Rescue Strategy in Budd–Chiari Syndrome
-
Aug 14, 2026, 13:18Immune Checkpoint Inhibitors Have Transformed Cancer Treatment – RPTH Journal
-
Aug 14, 2026, 13:04Mohammed M. Aboudeif: Cerebral Venous Thrombosis – Think Early, Treat Decisively
-
Aug 14, 2026, 12:49Ahmed Hawash: The Hawash Method for Managing Extreme ICU Complexity
-
Aug 14, 2026, 12:42Why Unfractionated Heparin Still Matters in Modern Anticoagulation – Thrombosis Canada
-
Aug 14, 2026, 11:40Liz Devlin: When HHT Affects More Than What We Can See
-
Aug 14, 2026, 11:29Archil Jaliashvili: Can Italy Reduce Its Dependence on Imported Plasma